Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Desloratadine as Adjuvant Therapy in Patients With Ulcerative Colitis

NCT07333716 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07333716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07333716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Desloratadine as Adjuvant Therapy in Patients With Ulcerative Colitis
Lead sponsor
Tanta University
Phase
Phase 2
Overall status
Recruiting
Start date
January 26, 2026
Completion date
March 31, 2027
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis, ulcerative colitis (uc)